Neurocrine Biosciences, Inc. (NBIX)
156.70
+1.20
(+0.77%)
USD |
NASDAQ |
May 22, 16:00
156.40
-0.30
(-0.19%)
After-Hours: 20:00
Neurocrine Biosciences EPS Diluted (Quarterly) : 1.914 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Soleno Therapeutics, Inc. | 0.5913 |
| Biogen, Inc. | 2.153 |
| Marker Therapeutics, Inc. | -0.1646 |
| Denali Therapeutics, Inc. | -0.6882 |
| Agenus, Inc. | 1.023 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 197.90M |
| Revenue (Quarterly) | 814.50M |
| Total Expenses (Quarterly) | 616.60M |
| Enterprise Value | 14.85B |
| Gross Profit Margin (Quarterly) | 98.31% |
| Profit Margin (Quarterly) | 24.30% |
| Earnings Yield | 4.15% |
| Operating Earnings Yield | 4.97% |
| Normalized Earnings Yield | 4.092 |